US Archives - Page 100 of 119 - European Medical Journal

Idiopathic Pulmonary Fibrosis Hospitalizations Worsen Patient Outcomes: CHEST 2024

Hospital stays lead to worsening fatigue and shortness of breath in patients with idiopathic pulmonary fibrosis (IPF) according to a new study presented at the CHEST 2024 Annual Meeting.

New Antibody Target in Marburg Virus: Vaccine Potential

Marburg virus survivors have been investigated in a new study that has identified a key immunogen in the virus’s wing domain that could revolutionize vaccine development.

Digital Health Boosts Lung Cancer Screening Rates: CHEST 2024

A digital health program, mPATH-Lung, has been shown to significantly improves lung cancer screening (LCS) rates among high-risk individuals.

Transforming Palliative Care in Underserved Populations: CHEST 2024

A new study presented at the CHEST Annual Meeting 2024 highlighted the success of a new clinic aimed at improving palliative care access.

Forecasting Tobacco-Free Generations by 2050

Accelerating the global decline in tobacco smoking could significantly increase life expectancy and prevent millions of premature deaths by 2050, according to new research.

Why Are Breast Cancer Diagnoses Rising?

Breast cancer deaths have declined by 44% since 1989, but rising diagnoses and racial disparities highlight the need for targeted care and early detection.

What Is the Effect of the Pandemic on Mental Health in Youth?

Findings reveal the effect of the pandemic on mental health in youth, showing a significant increase in depression and anxiety diagnoses during COVID-19.

Dupilumab Offers Benefits in Bullous Pemphigoid Management

A clinical trial has shown that dupilumab, a monoclonal antibody targeting IL-4 and IL-13, may offer benefits to patients in managing bullous pemphigoid, a rare autoimmune blistering disease.

Concerns With Pediatric Pneumonia Treatment In The U.S. Revealed

New Two-Dose Method Strengthens HIV Vaccine Response

A study highlights a significant advancement in HIV vaccine development: a two-dose priming strategy that optimizes the body’s immune response by aligning vaccine delivery with the germinal center (GC) reaction.